BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
SEEKYO Therapeutics
/
Oury Chetboun
OC
Oury Chetboun
CEO, Co-founder
SEEKYO Therapeutics
Therapeutic Areas
Oncology
Solid Tumors
SEEKYO Therapeutics Pipeline
Drug
Indication
Phase
SKY01
Solid Tumors (Pancreatic, TNBC, Lung, Colorectal)
Preclinical
SKY02
Solid Tumors
Preclinical
Leadership Team at SEEKYO Therapeutics
PS
Prof. Sebastien Papot
CSO, Co-founder
View full SEEKYO Therapeutics profile